CytomX Depreciation And Amortization from 2010 to 2025

CTMX Stock  USD 0.65  0.03  4.41%   
CytomX Therapeutics Depreciation And Amortization yearly trend continues to be fairly stable with very little volatility. Depreciation And Amortization will likely drop to about 2.3 M in 2025. Depreciation And Amortization is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. View All Fundamentals
 
Depreciation And Amortization  
First Reported
2014-03-31
Previous Quarter
459 K
Current Value
429 K
Quarterly Volatility
469.6 K
 
Yuan Drop
 
Covid
Check CytomX Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CytomX Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 2.1 M or Selling General Administrative of 28.8 M, as well as many indicators such as Price To Sales Ratio of 1.23, Dividend Yield of 0.0299 or Days Sales Outstanding of 13.52. CytomX financial statements analysis is a perfect complement when working with CytomX Therapeutics Valuation or Volatility modules.
  
Check out the analysis of CytomX Therapeutics Correlation against competitors.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.

Latest CytomX Therapeutics' Depreciation And Amortization Growth Pattern

Below is the plot of the Depreciation And Amortization of CytomX Therapeutics over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. CytomX Therapeutics' Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CytomX Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Depreciation And Amortization10 Years Trend
Slightly volatile
   Depreciation And Amortization   
       Timeline  

CytomX Depreciation And Amortization Regression Statistics

Arithmetic Mean1,880,672
Geometric Mean1,550,210
Coefficient Of Variation65.49
Mean Deviation882,297
Median1,884,000
Standard Deviation1,231,620
Sample Variance1.5T
Range4.8M
R-Value0.68
Mean Square Error875B
R-Squared0.46
Significance0
Slope175,760
Total Sum of Squares22.8T

CytomX Depreciation And Amortization History

20252.3 M
20242.5 M
20232.2 M
20222.4 M
20212.7 M
20205.5 M
20192.6 M

About CytomX Therapeutics Financial Statements

CytomX Therapeutics investors use historical fundamental indicators, such as CytomX Therapeutics' Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CytomX Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Depreciation And Amortization2.5 M2.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CytomX Stock Analysis

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.